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ABSTRACT

Alcohol abuse is the fourth leading cause of preventable death in the United
States (National Institute on Alcohol Abuse and Alcoholism [NIAAA], 2016). Alcohol
affects us on a molecular, biological, and even societal level. Liver damage, cancer, and
drunk driving accidents are only a few adverse consequences of alcohol abuse. Studies
have also shown that alcohol abuse can damage the brain, in part by activating the central
nervous system’s immune system, leading to inflammation and demyelination. This
damage may lead to alcohol-related psychiatric disorders, motor impairment, and
cognitive disabilities. Studies have also shown that females tend to exhibit more damage
with less alcohol consumption than males, and that genetic background influences
sensitivity to the drug. Thus, studying alcohol addiction at a biological level with special
care for how sex and genetic background influence this phenomenon is key to
understanding addiction and delivering effective treatment. In the present experiment, I
examined the brain’s immune response to alcohol withdrawal by performing
immunohistochemical analysis of microglial activation at two post-withdrawal time
points in female C3H/HeJ inbred mice. In this experiment, alcohol dependence was
induced using an ethanol-vapor exposure protocol shown previously in our lab to
generate long-lasting impairment of spontaneous behavioral activity.
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INTRODUCTION

Alcohol use is prevalent in many cultures, and its use ranges from social
gatherings to religious ceremonies. However, despite decades of stigmatism towards
individuals suffering from alcohol dependence, the abuse of alcohol is still one of the
leading causes of death in the U.S. and not only harms the abuser but their society as
well. Alcohol abuse has been shown to cause or exacerbate certain neurological
disorders, several types of cancers, road accidents, and other deleterious consequences
(World Health Organization [WHO], 2014). Currently, alcohol dependence is diagnosed
as Alcohol Use Disorder (AUD), a medical condition detailed in the Diagnostic and
Statistical Manual of Mental Disorders (DSM 5). Alcohol abuse is therefore not merely a
deviant behavior but a disease that needs treatment (NIAAA, “Alcohol Use Disorder”).
AUD is best defined as an addiction where a person actively seeks and consumes alcohol
excessively regardless of knowing the negative consequences of said actions. A person
who suffers from an AUD may want to stop but will have extreme difficulty doing so
(NIAAA, “Alcohol Use Disorder”), and are thus described as having “lost control” of
their drinking.
Brain Damage Associated with Ethanol Exposure
Ethanol, the form of alcohol found in alcoholic beverages, is a small polar
molecule consisting only of 2 carbons, 1 oxygen, and 6 hydrogens that easily transverses
epithelial linings such as the gastrointestinal tissue (National Center for Biotechnology
Information [NCBI], n.d). This pervasiveness causes alcohol to permeate throughout the
body via the circulatory system.
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Human and animal studies have shown that alcohol abuse impacts the liver,
pancreas, heart, and central nervous system, sometimes causing permanent damage such
as liver scarring and cardiomyopathy (NIAAA, “Alcohol’s Effects on the Body”).
Though damage to any of these organs can be life-threatening, damage to the nervous
system can cause psychological changes such as memory loss, motor impairment, mood
disorder, addiction, and a change in personality.
Alcohol abuse causes the brain to undergo changes ranging from a
macrostructural to a molecular scale, including large lesions, neuronal degradation,
dendritic spine morphological changes, and even altered neurotransmitter response (Gass,
2012). Starting from the macrostructural changes, the brains of alcoholics in both animals
and humans are smaller than their non-alcoholic counterparts. With imaging analyses
such as magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI), studies
have also shown that ventricular cavities are larger and myelin integrity is decreased in
alcoholic models (Pfefferbaum, Rosenbloom, Rohlfing, & Sullivan, 2009; Zahr, et al.,
2010, “Brain Injury”). Within the brain, several nuclei, white matter fiber tracts, and
other areas seem to be particularly susceptible to damage such as demyelination and a
cessation of neurogenesis. These areas include the frontal lobe, corpus callosum,
hypothalamus, and hippocampus (Pfefferbaum et al., 2009; & Crews & Nixon, 2008; He,
Sullivan, Stankovic, Harper, Pfefferbaum, 2007; Chastain & Sarkar, 2014; Mayfield,
Lewohl, Dodd, Herlihy, Liu, Harris, 2002). Each of these regions play an important role
not limited to integrating the cerebral hemispheres together and/or other brain structures,
memory formation, and behavior respectively. The frontal lobe in particular is associated
with decision making, attention, and impulse inhibition. As a result of this damage, long-
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term human alcoholics are afflicted with impaired judgement, attention deficit, and lack
of impulse control (Crews, 2008). Both alcoholic animals and humans also display
learning and memory deficits, and depression and anxiety-like behaviors (Yang et al.,
2014; Pascual, Balino, Aragon, Guerri, 2015; Crews, 2008; and Pfefferbaum et al., 2009).
Demyelination/Neuronal Level
On a neuronal level, demyelination may not always kill neurons, but can
nevertheless have disastrous effects on brain function. Myelin is a whitish fatty substance
produced by Schwann cells and oligondendrocytes. These specialized cells create sheaths
along neuron axons to increase conduction speed. Affecting the speed and
communication of neurons can greatly interfere with their function. Demyelination also
occurs in multiple sclerosis, HIV, and central pontine myelinolysis (Love, 2006).
Through the use of quantitative fiber tracking quantified from diffusion tensor
imaging (DTI), Pfefferbaum and his lab saw that neuron fiber integrity was degraded in
human chronic alcohol users, especially in anterior (internal and external capsules, frontal
forceps, and fornix) and superior (superior cingulate) association fibers. The extent of
damage in these areas positively correlated with the years the participants used alcohol.
Cognitive and motor tests such as balancing on one foot and completing digit symbol
grids were also conducted in Pfefferbaum’s study. They found that myelin damage
negatively correlated with test scores (Pfefferbaum et al., 2009).
Immune Response & Microglia
Although the exact mechanisms that cause myelin destruction and other forms of
ethanol -created damage in the brain are yet to be known, several biochemical pathways

4
and immune responses have been found to become activated with alcohol abuse. Of
special interest are microglia. Microglia are the primary immune system cell of the
central nervous system and perform phagocytosis, release immune factors, and initiate
apoptosis allowing damage, debris, and foreign invaders to be taken care of by the on-site
microglia and other responding immune cells (Chastain, Sarkar, 2014). While resting,
microglia are usually ramified, but upon activation will become amoeboid as they
proliferate and perform their immune system duties. Activated microglia can be further
identified by their cytokine phenotype. The M1 phenotype releases proinflammatory
factors while the M2 phenotype releases anti-inflammatory factors (Chastain & Sarkar,
2014). The role of the microglia is indispensable; however, studies have linked microglial
activation to neuroinflammation and subsequent damage seen in alcoholics (FernandezLizarbe, Pascual, Guerri, 2009; Boyadjieva, Sarkar, 2013; Chastain, Sarkar, 2014;
Pascual et al., 2015).
Microglia are thought to afflict damage by overreacting to the ethanol exposure
through 2 different pathways: oxidative stress from pro-inflammatory cytokines and
neuroinflammation. Ethanol exposure alters the expression of certain genes and
transcription factors important for protecting neurons. Ethanol increases nuclear factor
κB (NF-κB) transcription which has roles in inflammatory and other immune responses.
cAMP responsive element-binding protein or CREB family transcription factors transcription factors involved in the survival of neurons and protecting neurons from
excitotoxicity- are down-regulated (Crews, Nixon, 2008).
Fernandez-Lizarbe et al. found that ethanol exposure in mouse microglial cell
cultures for 24 and 48 hours significantly increased TNF-a, IL-1B, and NO, and that
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these levels of factors in the medium would initiate apoptosis in cultured cortical cells.
The researchers also introduced just ethanol -without the microglia released factorsdirectly into the media of cortical cells and did not find a significant increase in apoptosis
suggesting it was the factors the microglia in the ethanol exposure media released and not
the ethanol in that media that increased the apoptosis in the cortical cells (FernandezLizarbe et al., 2009). Boyadjieva and Sarkar in their 2013 study used rat cell cultures of
microglia and developing hypothalamic cells to test oxidative stress and apoptosis in
relation to ethanol exposure. They found that hypothalamic cells exposed to ethanol and
ethanol treated microglia cell culture medium increased the levels of oxidants such as
reactive oxygen species (ROS) and nitrite, lowered antioxidant levels, and increased
apoptotic death in the developing hypothalamic cells. However, the presence of ethanol
treated microglia cell culture medium had more elevated levels of oxidative stress
response and cell death than the introduction of ethanol alone (Boyadjieva, N., Sarkar,
K., 2013).
Though microglial activation does seem to play a significant role in the central
nervous system’s response to ethanol, its role is more complex than once believed. As
stated before, neuroinflammation has been linked with microglial activation, but it may
be a consequence of the neuroinflammation rather than the cause in certain scenarios.
In Marshall et al.’s paper published in 2013, they used a 4-day binge ethanol
protocol on rats and saw that there was not a significant increase in pro-inflammatory
cytokines such as IL-6 and TNF-a between the ethanol and control animals. There was in
fact a decrease of IL-6 in the entorhinal cortex on day 2 but on no other days. They also
found that the number of microglia depended on the region of the brain such as the
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entorhinal cortex or hippocampus. They found no significant change in the amount of
microglia in the entorhinal cortex but that an increase in microglia persisted in some
regions of the hippocampus for 28 days.
They then decided to measure anti-inflammatory factors in these regions. They
found that levels of the growth factor, TGF-B, and the anti-inflammatory cytokine, IL-10,
were significantly increased on the 7th day of abstinence in the hippocampus. There was
also a lack of disruption of the blood brain barrier which is a classic marker for
neuroinflammation. These results suggest that the microglia were having a more
ameliorative effect perhaps preventing neuroinflammation in this 4-day binge protocol
rather than causing it (Marshall et al., 2013).
Another aspect of the immune system that has been studied in association with
ethanol exposure are the toll-like receptors with a special emphasis on Toll like receptor
4. Toll-like Receptor 4 (TLR4), a receptor associated with the immune system that
detects bacterial endotoxin, is a gene expressed in microglia. Knocking out this gene has
been shown to alleviate demyelination in ethanol exposed mice. Alfonso-Loeches et al.
compared demyelination levels via Western Blot, immunohistochemistry, and mRNA
expression between wildtype (WT) C57BL/6 female mice and TLR4 knockout (KO)
C57BL/6 female mice exposed ethanol. As expected, the WT mice exposed to ethanol
had more demyelination, less myelin associated proteins, and lower levels of myelinassociated mRNA. The amount of demyelination, myelin associated proteins, and levels
of myelin-associated mRNA in the TLR4 KO-mice exposed to ethanol was not
significantly different from the TLR4 KO mice not exposed to ethanol. They also saw
that the amount of neural degeneration between WT control mice, TLR4 KO control
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mice, and TLR4 KO ethanol exposed mice were not significantly different while the WT
ethanol exposed mice had significantly more degenerated neurons with a p<0.01
(Alfonso-Loeches, Pascual, Gomez-Pinedo, Pascual-Lucas, Renau-Piqueras, Guerri,
2012). Pascual et al. saw through electron microscopy that myelin sheath damage in
ethanol exposed TLR-4 intact mice was between 40%-50% in the corpus callosum and
cerebral cortex and that ethanol exposed TLR-4 KO mice sustained between 4%-8%
damage (Pascual et al., 2015).
Alteration in Brain Genetics/Genomics
Gene expression in the brain tissue of mice is altered depending on the stage of
addiction, the sex of the animal, and the strain. Koob and Volkow in 2010 have described
alcoholism as having 3 stages: intoxication, withdrawal, and abstinence/craving (as cited
by Wilhelm, Hashimoto, Roberts, Sonmez, & Wiren, 2014). Wilhelm’s lab studied gene
expression and gene networks during these different stages of alcoholism in two
divergent mouse lines (Withdrawal Seizure Prone [WSP] and Withdrawal Seizure
Resistant [WSR]) and both sexes. He found that there were substantial differences in
which types of genes were upregulated and downregulated depending on sex and genetic
background during the intoxication stage and the peak of ethanol withdrawal. These sex
differences were then negligible after 21 days of abstinence. At this point in abstinence,
strain differences were seen. However, both sexes had significant upregulation of
inflammation/immune function genes (Wilhelm et al., 2014).
In general, females tend to be more susceptible to damage with less alcohol
consumption than males (Alfonso-Loeches, Pascual, & Guerri, 2013). Several sources of
this dimorphism have been identified. Baraonoa et al. in 2001 found that females have
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less alcohol dehydrogenase in their livers (as cited by Wilhelm et al., 2014) and
Addolorado et al. in 1999 found that females have different lipid and water ethanol
partitioning than males (as cited by Wilhelm et al., 2014).
In Marshall et al.’s study from 2013, it was found that male WSR mice had
increased expression of Zswim7, a gene associated with damaged DNA repair, during
withdrawal and abstinence. The most regulated transcripts were found in the females of
both strains further suggesting that females are more sensitive to the effects of alcohol.
Though, the most highly regulated genes in females involved sexual differentiation, cell
death/neurodegeneration, and genes associated with gonadal/breast/prostate diseases.
Males most highly regulated genes involved transmembrane action/signal peptide
enrichment, nervous system disorders/development, mitochondria, and
peroxisome/lysosome functions (Marshall et al., 2013).
Along with affecting gene expression, ethanol has been studied on its ability to
cause mutations in the genome. Benassi-Evans and Fenech conducted a study showing
that ethanol significantly increased aneuploidy in chromosome 17 and other
chromosomal aberrations such as nuclear budding. Genetic abnormalities in chromosome
17 are characteristic of breast cancer cells. They studied this phenomena in 2 different
cell lines. One cell line had a breast cancer background (GM13705) and the other cell line
had an inactivating mutation in the p53 gene which has also been linked with cancer but
immortalized the cell line (WIL2-NS) to see if the genetic background affected alcohol’s
ability to cause genetic abnormalities. They found that GM13705 was more resistant to
the genomic mutagenic effects of alcohol than WIL2-NS. Nuclear budding, micronuclei
cells, and nuclear plasma bridges (all markers for genetic abnormalities) were
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significantly increased in the ethanol treated WIL2-NS cells compared to the control
WIL2-NS cells starting from the first week of treatment while the GM13705 cell line
started showing significant changes between experimental and control cells during week
3. Aneuploidy in chromosome increased significantly from controls in both lines
(Benassi-Evans, Fenech, 2011).

Other studies have found evidence that acetaldehyde, a byproduct of metabolizing
alcohol, may also cause genetic abnormalities. These mutations may also be impacted by
how much alcohol dehydrogenase, the chemical in our body that breaks down alcohol, is
produced by the organism’s system which is determined by genetic background (BenassiEvans, Fenech, 2011). In fact, Ishiwaka et al.’s study in 2003 showed an association with
human alcoholics having a genotype that is deficient in alcohol dehydrogenase (as cited
by Benassi-Evans, Fenech, 2011).
My Project
These studies show that more research needs to be put into studying the biological
differences in AUD cases in order to provide appropriate and effective treatment
especially in genetically predisposed females who are more susceptible to such damage.
This background research provides the basis for this exploratory thesis project.
I chose the mouse model because studies on human alcoholics are limited due to a
lack of a scientific control. The mouse model is a favorable mammal model in general
due to its genetic similarity to humans (National Human Genome Research Institute
[NHGRI], 2012), and its ability to breed quickly allowing researchers to narrow down
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genes, behaviors, and other factors that may show definitive consequences or
susceptibilities of alcohol use.
Many strains of mice have been tested for ethanol preference, withdrawal
severity, and other components of alcohol use disorder in behavioral, kinetic, and
pharmaceutical studies. Female C3H/HeJ mice were chosen for this project due to
females typically sustaining more brain damage and more severe behavioral issues than
their male counterparts, and the C3H/HeJ line being more sensitive to ethanol abuse on a
handling induced convulsions test spectrum (Meeten and Crabbe, 2005). Metten and
Crabbe in 2005 indexed several popular inbred strains of mice by studying handling
induced convulsion in the mice after 25 hours of ethanol exposure.
The role of microglia in ethanol addiction is being actively explored and therefore
provides a plethora of new exciting research from which to study and add onto. I studied
microglial proliferation via Iba-1 antibody staining (a popular stain for detecting and
quantifying microglial activation).
I studied the amount of microglial proliferation immediately after ethanol
withdrawal and 1 week of abstinence due to the time sensitive nature of microglial
activation and proliferation. I also wanted to learn and utilize all the techniques
associated with this experiment starting from CIE protocol to immunohistochemistry
staining. I chose the prefrontal cortex area due to its importance in decision making, it’s
susceptibility to ethanol-associated damage, and the relative ease it is found and accessed.
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METHODS

Animals & Apparatus
Female C3H/HeJ (C3H) mice (n=16) were obtained from the Jackson
Laboratories (Bar Harbor, ME) at about 6 weeks of age. Immediately upon arrival, the
mice were weighed and group-housed in one of four cages in a Plexiglas inhalation
chamber (60 x 36 x 60 cm). Two cages and therefore two groups of mice were exposed to
ethanol vapor via a 10-day chronic intermittent ethanol vapor exposure CIE protocol.
Two other cages and therefore two other groups of mice were exposed to a plain-air
control. Before being exposed to their respective treatments, the mice were group housed
in the chambers with plain-air and maintained under a light-dark (LD) 12:12 cycle for 15
days to allow for acclimation to the cages and environment. This was to avoid the effects
that the stress and adjustment period of their new housing arrangements could have on
the results of the study. After this acclimation period, the mice were then put through
their respective protocols. Each day, the ethanol treated mice were exposed to 16 hours of
ethanol at the onset of their dark cycle (meaning 12 hours of ethanol exposure in the dark
phase and 4 hours of ethanol exposure in the light phase) and then 8 hours of plain-air.
This cycle repeated throughout the duration of the 10-day protocol.
Chronic Intermittent Ethanol (CIE) Procedure Details
The 10-day CIE protocol exposure used in this experiment is based off Dr. Alan
Rosenwasser’s lab protocol. Along with the ethanol exposure, all animals were
administered intraperitoneal injections. Ethanol treatment mice were injected with 1.6
g/kg ethanol and 68.1 mg/kg pyrazole HCl solution. This injection is used to prime the
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animals for the ethanol exposure. Mice typically metabolize ethanol rapidly, so by
administering pyrazole HCl, an alcohol dehydrogenase inhibitor, it allows ethanol to
concentrate in and stabilize the animal’s blood alcohol levels (Logan, McCulley, Seggio,
and Rosenwasser, 2012). The pyrazole HCl was dissolved in 20% v/v ethanol solution
and injected at a volume of 20 ml/kg. The control mice were administered an identical
dose of pyrazole HCl in a 0.9% solution at the same volume ratio to mimic the effects of
pyrazole in the animal’s system and the stress of being handled and having an injection in
both groups.
Ethanol vapor and air were delivered to the Plexiglas exposure chambers at a rate
of 10-12 liters per minute to ensure adequate air flow for the animals’ breathing
requirements. The ethanol chamber was tested via breathalyzer (Lifeloc FC-10; Wheat
Ridge, CO) to ensure that the mice were also exposed to an adequate amount of ethanol
to become intoxicated. This was tested by extracting 5.0 ml air samples from the ethanol
chamber via 60 ml syringe. The 5.0 ml sample was then diluted with 55 ml of plain-air
and injected steadily into a breathalyzer.
At the end of this protocol, the blood ethanol concentrations (BEC) were
measured. Each mouse was briefly put in a plastic restraining tube where a small blood
sample (~10 µl) was obtained through the cut made on the tip of the tail made via
razorblade. The blood was collected directly into a heparinized capillary tube and
centrifuged for 2 minutes to separate the serum from the plasma. BECs were determined
from 5 µl plasma samples using an AM-1 alcohol analyzer (Analox Instr., Lunenberg,
MA). The average blood ethanol concentration was 168.7 mg/dL ± 16.8 mg/dL.
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Tissue Extraction
Half of the animals (1 group of EtOH exposed animals (n=4) and 1 group of aironly exposed animals (n=4)) were transcardially perfused after their blood was drawn for
BEC. The other half (1 group of EtOH exposed animals (n=4) and 1 group of air-only
exposed animals (n=4)) were put into hamster cages (42.5 x 21 x 21.6 cm) out of the
vapor chambers and were transcardially perfused 7 days later.
Transcardial Perfusion
A 10:1 mg/mL ratio of ketamine:xylazine cocktail at 10 ml/kg bodyweight was
administered intramuscularly to each animal in the thigh muscle to anaesthetize them
before the procedure. An extra 0.05mL ketamine/xylazine cocktail was administered to
each mouse if they still responded to pinching of the toes 15 minutes after the initial dose.
The mice were held during this process to ensure they stayed warm since they could no
longer thermoregulate properly.
An incision was then made into the chest cavity of the mouse allowing access to
the heart. I needle was then inserted into the heart. After the needle was clipped in, I
turned on the automated syringe-pump machine making sure to snip the atrium after
starting the process. The mouse was perfused with approximately 20mL of PBS and then
approximately 20mL of 4% PFA. The mouse was then decapitated with bone scissors.
The brain was then extracted from the skull, put into a labeled cassette, and then
submerged into 4% PFA solution. The needle of the automated syringe-pump machine
was then washed with another PBS plunger to clean the tubing from residual 4% PFA.
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After all the brains were extracted, put into their respective cassettes, and
submerged in 4% PFA, the container holding the cassettes and 4% PFA were put into a
4C fridge for approximately 24 hours. The brains were then transferred into a container
holding 5% sucrose solution for approximately 48 hours. The brains were then
transferred into a 15% sucrose solution for approximately 48 hours. Then into 30%
sucrose solution for approximately another 6 days.
The tissue was then separated into 3 coronal sections with each section frozen
separately in Optimal Cutting Temperature (OCT) compound inside a labeled cryomold.
After all the brains were frozen, the cryomolds containing the tissue were put into a -20C
freezer until they could be put in the cryostat. I made a mistake by not ensuring that the
tissue stayed cold throughout this process. This was probably the reason there were holes
in the tissue seen at the microscopic level. Freezing, then thawing, then freezing the
tissue most likely allowed ice crystals to form and rupture the tissue causing pockets in
the tissue which can be seen in the Results. The fridge they were being stored in also
malfunctioned while the tissue was in it which may have compounded with the initial
rethawing and freezing process.
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Figure 1. Atlas of the Mouse Brain and Spinal Cord. (Sidman, Angevine, Pierce, 1971). A lateral view
(left) and ventral view (right) of how the sections were partitioned out. Section A: ~ 0 micron - 220
microns. Section B: ~ 220 microns – 370 microns. Section C: ~ 370+ microns.

Tissue Slicing & Staining
Section A contained the prefrontal cortex and was therefore the only section that
was cut and stained. Each section was cut at 10 microns. At least 8 slices were extracted
from each animal. 2 sections were put onto each slide. The slides were left to incubate at
37C overnight and then put into -20C until they could be stained.
Iba-1 Immunohistochemistry Protocol
This immunohistochemistry protocol was modified from Dr. Thane Fremouw’s
Iba-1 immunohistochemistry staining protocol for 40 micron brain tissue and Dr. Kristy
Townsend’s immunofluorescence for 7-10 micron brain tissue protocol.
On Day 1, the slides were first washed with 0.05 KPBS for ten minutes to wash
off the OCT compound. The slides were then transferred to a 1% hydrogen peroxide
solution diluted in 0.05KPBS for 15 minutes. The slides were then washed 4 times for 5minute intervals in 0.05KPBS solution.
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A PAP pen was used to circumscribe wells for each tissue section. 100 microliters
of Iba-1 primary antibody (1:40,000 dilution in 0.05KPBS/0.4% Triton X-100) was put
into each of these wells and allowed to incubate at room temperature for 1 hour before
being put into a fridge for 23 hours.
The slides were then rinsed with 4 6-minute washes of 0.05 KPBS. The PAP pen
wells were redrawn if needed. 100 microliters of biotinylated secondary antibody (1:500
in 0.05M KPBS/ 0.4% Triton X-100) was then put into each well at room temperature for
1 hour. The slides were then washed with 5 10-minute washes of 0.05 M KPBS. After the
washes, 100 microliters of A/B solution prepared from an Vectastain Elite Kit (1 drop of
A, 1 drop of B, and 10mL 0.05 M KPBS/0.4% Triton X-100) were put into each well to
incubate for 1 hour at room temperature. They were then rinsed with 3 5-minute washes
in 0.05 M KPBS. The slides were then rinsed with 3 5-minute washes of 0.175 M sodium
acetate. 100 microliters of NiDAB was then put into each well and allowed to incubate at
room temperature for 23 minutes. The NiDAB was then extracted via pipette and 100
microliters of sodium acetate was put into each well to stop the reaction. The slides were
then put into a 10-minute wash of 0.175 M sodium acetate. After, the slides were rinsed
with 2 5-minute washes of 0.05 M KPBS. The slides were then allowed to dry over night
at room temperature.
Coverslipping Slides
The slides were put into an ethanol dilution series starting at 70% for 2 minutes,
then 95% ethanol for 2 minutes, then 100% ethanol for 2 minutes, and finally into
another 100% ethanol solution for 2 minutes. After the ethanol dehydration process, the
slides were put in Histoclear for 5 minutes and then into another container of Histoclear
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for another 5 minutes. After this, Permount mounting medium was put onto the tissue and
a coverslip put on top of the solution. Tweezers were used to gently push bubbles out
from underneath the coverslip. The Permount was then allowed to dry overnight before
they were viewed underneath a microscope.
A second batch of slides went through 3 containers of Histoclear to see if this
would clear the bubbles found in the first batch.
Statistics & Analysis
The microglia were counted manually and a two-way(treatment*day) ANOVA of
the average microglia cell count of each animal was calculated through SPSS. I counted
the microglia from one 650 micron x 430 micron sample from each hemisphere at
varying depths of the prefrontal medial cortex of each mouse whose tissue was not too
damaged (example photos Figure 2.C-E). This data can be seen in Table 1. The slides
were haphazardly blinded by randomly assigning numbers to each slide and covering the
original label to deter from counting bias.
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RESULTS

Blood Ethanol Concentrations & Average Microglia Count
NIAAA defines binge drinking as a pattern of drinking that brings blood alcohol
concentration (BAC) levels to 0.08 g/dL. This typically occurs after consuming 4 drinks
for women and 5 drinks for men in the span of 2 hours. BAC of 0.1 (0.1% or one tenth of
one percent) means that there are 0.10 g of alcohol for every dL of blood (NIAAA,
“Drinking Levels Defined”). Included in this table as well is the average microglia cell
count per 650 micron x 430 micron sample for each animal.
Mouse (treatment, day after CIE, #)
C01 (ex. Control, Day 0, Mouse #1)
C02
C03
C04
E01
E02
E03
E04
C75
C76
C77
C78
E75
E76
E77
E78
Mean ± Standard Error

BEC after CIE
mg/dL
NA
NA
NA
NA
195.6
165.2
160.8
130.4
NA
NA
NA
NA
(126.1+143.4)/2=13
4.8
191.3
(104.3+117.3)/2=11
0.8
(243.4+278.2)/2=26
0.8
168.7 ± 16.8

Average Microglia
Count
6.5
4.5
7.5
6.25
5
4
5.5
5
8.9
7.25
10
9
6.416666667
5.333333333
7.25
5.076923077
6.5

Table 1. The blood ethanol concentration of each animal in mg/dL immediately after finishing the CIE
protocol and microglia cell count. BECs were not taken from controls because they were not exposed to
ethanol. All ethanol treated mice were above 100 mg/dL meaning they had all achieved a level of
intoxication comparable to binge drinking as described above. The microglia cell counts are averages of the
number of cells per 650 micron x 430 micron sample for each animal.

19
Microglial Staining
The microglia did stain, but the brain tissue had many holes in it making proper
counting let alone morphological analysis of the microglia very tough. Slides that were
too damaged (such as A and B below) were not counted. The holes were probably caused
by improper freezing allowing ice crystals to form in the tissue.

Figure 2: Light microscopy of microglia expressing Iba-1 in several different animals. Images A and B are
100x photos of the entire medial prefrontal cortex and are examples of how severe the tissue damage was.
Images C and D are at 400x and display resting and/or low stages of activation. Image E and F show
thicker ramifications with F being a zoomed in highly ramified microglia. Images C and E also show an
odd bubbling phenomena in the permount that was only noticeable under a microscope. The white arrows
point to some iba-1 stained microglia. The cell counts were conducted with photos such as C-E each image
being 650 microns wide x 430 microns long x 10 microns thick.
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Figure 3. Graph and Descriptive Statistics Tables. A Two-Way ANOVA was performed using SPSS, a
computer program able to perform statistical tests, on 16 female C3H/HeJ mice to examine the effects of
ethanol exposure and day after withdrawal on mean microglia count in the mPFC. The data used is in the
third column (Average Microglia Count) of Table 1. A significant main effect was found between Days
with less microglia being present in the Day 7 animals (p=0.003). Another significant main effect was
found between Treatments with ethanol animals having more microglia (p=0.002). There was no significant
interaction between Day and Treatment (p=0.18).
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DISCUSSION

This pilot study found that time and treatment respectively significantly affected
the amount of microglia in the medial prefrontal cortex (mPFC). There were more
microglia present immediately after withdrawal than one week later and the ethanol
treated mice had more microglia than the control mice.
Based on previous studies, I expected to see an increase or similar level of
microglial activation and proliferation in EtOH mice from Day 7 as Day 0 rather than a
decrease. In McClain et al.’s study, they studied microglia morphology and activation in
adolescent rats (35 days postnatal) at three time points- 2 days after the last ethanol
exposure (T2), 7 days after (T7), and 30 days after (T30). They saw that at T2 that there
were significant morphological changes in microglia in the hippocampus and that there
were significantly more microglia in the ethanol treated mice. They saw that this pattern
continued beyond the 2 days and persisted to T30 (McClain, Morris, Deeny, Marshall,
Hayes, Kiser, Nixon, 2011). Two years later, the same lab studied microglial activation
again at T7 and T28 but focused on blood brain barrier disruption, cytokines, and
differences within the different regions of the hippocampus and entorhinal cxortex. They
found that by T28, the amount of hippocampal microglia in the ethanol treated rats was
not significantly different from the control rats except in the subregion CA2/3. They also
found that anti-inflammatory cytokines were being released significantly more than proinflammatory factors in ethanol exposed animals at T7 suggesting that the microglial
were displaying more of a partially activated M2 phenotype. Partial activation in
microglia is more closely correlated to neuroprotection rather than neuroinflammation
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debunking that microglial activation caused by ethanol exposure always equals
neuroinflammation (Marshall et al., 2013). These studies suggest that there is a temporal
and regional affect that should be studied more.

Figure 4. Images from McClain et al.’s “Adolescent binge alcohol exposure induces long-lasting partial
activation of microglia” at T2 in the hippocampus. Displayed are dozens of microglia with stained for Iba1 expression. These pictures are an ideal comparison between the differences in thickness of processes and
quantity of microglia between control and EtOH treated rodent brain tissue.

The results of my pilot experiment suggest that microglia in female C3H/HeJ
mice decrease after the 10-day CIE treatment itself in both control and ethanol animals
with ethanol animals consistently having more microglia than the control animals during
the two tested time points. This may mean the stress of the 10-day CIE protocol causes an
increase in microglia for all animals involved with ethanol exacerbating the microglia
increase and causing this increase to last for at least a week after the CIE protocol. This
effect by days may also be due to a small n. The decrease in microglia from Day 0 to Day
7 is more severe in the ethanol treated mice with a difference of 2.7675 microglia while
the control mice decrease 1.3125 microglia (Figure 3). Previous studies have also found
that different ethanol dependence protocols have different effects on microglial activation
in different rodent models. Marshall et al. did a 4-day binge ethanol protocol in rats and
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got M2 phenotype microglia while other studies have found that chronic intermittent
ethanol exposure tends to cause a M1 phenotype in microglia in mice (Marshall et al.,
2013). These results may also be due to the brain region. Perhaps microglial activation is
different in the mPFC as compared to the hippocampus and entorhinal cortex.
However, this pilot study had few animals per group (n=4 per group) and the
tissue was damaged. The cells were also an average of cells from different coronal levels
of the mPFC. Future studies would want to stay consistent with the depth of the tissue
and separate the subregions of the mPFC (the infralimbic region, prelimbic area, and
anterior cingulate gyrus) as some other studies have done with the studying the
subregions of the hippocampus.
If I were to go further with this experiment, I would have a higher n. I would also
have another type of control mouse that would not go through any part of the treatment to
see how much of an impact the stress of the protocol affects the microglial response. I
would add another time point at about 30 days after last exposure to ethanol to see if
microglia in the medial prefrontal cortex are still significantly different from the controls.
This study due to time constraints and damaged tissue could not look at the phenotype of
the microglia. This can be done through analyzing the ramification of the microglia to see
if the cells are amoeboid, have bushy processes, or other signs of activation. I would also
want to look at the cytokines being released at the different timepoints to get a better idea
of how activated the microglia are and what phenotype they are displaying. I would also
probably slice the whole brain so that it was easier to track the depth of the brain tissue
and to study other areas of the brain such as the hippocampus and cerebellum to compare
them with each other.
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Another exciting aspect of this project that could be explored is the role of TLR4.
As discussed in the Introduction, TLR4 plays a crucial role in the immune system’s
response to ethanol exposure. C3H/HeJ mice have a mutated TLR4 making them more
resistant to endotoxin (Jackson Labs, n.d.). This aspect of this strain may be partially
responsible for the results seen in this study. Studies have seen that a knocked out TLR4
significantly decreases microglia response, neuroinflammation, and demyelination
(Fernandez-Lizarbe et al., 2009, Alfonso-Loeches et al., 2013, Alfonso-Loeches et al.,
2013). TLR4 KO mice exposed to ethanol also do not show the memory and learning
deficits associated with ethanol exposure in WT mice (Pascual, Balino, Alfonso-Loeches,
Aragon, Guerri, 2011). I believe it would be interesting to replace the C3H/HeJ’s mutated
allele with other versions like the high ethanol preferring C57BL/6 to see if it affects
microglial response.
No matter how this topic is explored further, future studies into alcohol
dependence and exposure are paramount to finding better treatments for all and
understanding the effects alcohol has on us.
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APPENDIX

AUD- Alcohol Use Disorder
BAC/BEC- Blood Alcohol Concentration/ Blood Ethanol Concentration
CIE- Chronic Intermittent Ethanol
C3H- C3H/HeJ
DSM 5- Diagnostic and Statistical Manual of Mental Disorders
DTI- Diffusion Tensor Imaging
Iba1- Ionized calcium binding adaptor molecule 1
KO-Knockout
LD- Light-Dark
mPFC- medial Prefrontal Cortex
MRI- Magnetic Resonance Imaging
NCBI- National Center for Biotechnology
NF-κB- Nuclear Factor-κB
NHGRI- National Human Genome Research Institute
NIAAA- National Institute on Alcohol Abuse and Alcoholism
OCT- Optimal Cutting Temperature
T#- Timepoint Day
TLR4- Toll-like Receptor 4
WHO- World Health Organization
WSP- Withdrawal Seizure Prone
WSR-Withdrawal Seizure Resistant
WT-Wild Type
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Use Committee (IACUC). University of Maine Animal Welfare Assurance #: A3754-01.
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